Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
This report aims to provide a comprehensive presentation of the global market for Multiple Myeloma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Myeloma Therapy. This report contains market size and forecasts of Multiple Myeloma Therapy in global, including the following market information:
Global Multiple Myeloma Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Multiple Myeloma Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Targeted Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Multiple Myeloma Therapy include Sanofi, Celgene, Johnson & Johnson, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc., Novartis AG and Millennium Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Multiple Myeloma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiple Myeloma Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Multiple Myeloma Therapy Market Segment Percentages, by Type, 2022 (%)
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others
Global Multiple Myeloma Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Multiple Myeloma Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Multiple Myeloma Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Multiple Myeloma Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiple Myeloma Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Multiple Myeloma Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Celgene
Johnson & Johnson
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Amgen Inc.
Novartis AG
Millennium Pharmaceuticals
Innate Pharma SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multiple Myeloma Therapy, market overview.
Chapter 2: Global Multiple Myeloma Therapy market size in revenue.
Chapter 3: Detailed analysis of Multiple Myeloma Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multiple Myeloma Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Multiple Myeloma Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multiple Myeloma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multiple Myeloma Therapy Overall Market Size
2.1 Global Multiple Myeloma Therapy Market Size: 2022 VS 2030
2.2 Global Multiple Myeloma Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Multiple Myeloma Therapy Players in Global Market
3.2 Top Global Multiple Myeloma Therapy Companies Ranked by Revenue
3.3 Global Multiple Myeloma Therapy Revenue by Companies
3.4 Top 3 and Top 5 Multiple Myeloma Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Multiple Myeloma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Multiple Myeloma Therapy Players in Global Market
3.6.1 List of Global Tier 1 Multiple Myeloma Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Multiple Myeloma Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Multiple Myeloma Therapy Market Size Markets, 2022 & 2030
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Radiotherapy
4.1.5 Bone Marrow Transplant
4.1.6 Others
4.2 By Type - Global Multiple Myeloma Therapy Revenue & Forecasts
4.2.1 By Type - Global Multiple Myeloma Therapy Revenue, 2018-2023
4.2.2 By Type - Global Multiple Myeloma Therapy Revenue, 2024-2030
4.2.3 By Type - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multiple Myeloma Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Multiple Myeloma Therapy Revenue & Forecasts
5.2.1 By Application - Global Multiple Myeloma Therapy Revenue, 2018-2023
5.2.2 By Application - Global Multiple Myeloma Therapy Revenue, 2024-2030
5.2.3 By Application - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Multiple Myeloma Therapy Market Size, 2022 & 2030
6.2 By Region - Global Multiple Myeloma Therapy Revenue & Forecasts
6.2.1 By Region - Global Multiple Myeloma Therapy Revenue, 2018-2023
6.2.2 By Region - Global Multiple Myeloma Therapy Revenue, 2024-2030
6.2.3 By Region - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Multiple Myeloma Therapy Revenue, 2018-2030
6.3.2 US Multiple Myeloma Therapy Market Size, 2018-2030
6.3.3 Canada Multiple Myeloma Therapy Market Size, 2018-2030
6.3.4 Mexico Multiple Myeloma Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Multiple Myeloma Therapy Revenue, 2018-2030
6.4.2 Germany Multiple Myeloma Therapy Market Size, 2018-2030
6.4.3 France Multiple Myeloma Therapy Market Size, 2018-2030
6.4.4 U.K. Multiple Myeloma Therapy Market Size, 2018-2030
6.4.5 Italy Multiple Myeloma Therapy Market Size, 2018-2030
6.4.6 Russia Multiple Myeloma Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Multiple Myeloma Therapy Market Size, 2018-2030
6.4.8 Benelux Multiple Myeloma Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Multiple Myeloma Therapy Revenue, 2018-2030
6.5.2 China Multiple Myeloma Therapy Market Size, 2018-2030
6.5.3 Japan Multiple Myeloma Therapy Market Size, 2018-2030
6.5.4 South Korea Multiple Myeloma Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Multiple Myeloma Therapy Market Size, 2018-2030
6.5.6 India Multiple Myeloma Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Multiple Myeloma Therapy Revenue, 2018-2030
6.6.2 Brazil Multiple Myeloma Therapy Market Size, 2018-2030
6.6.3 Argentina Multiple Myeloma Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Multiple Myeloma Therapy Revenue, 2018-2030
6.7.2 Turkey Multiple Myeloma Therapy Market Size, 2018-2030
6.7.3 Israel Multiple Myeloma Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Multiple Myeloma Therapy Market Size, 2018-2030
6.7.5 UAE Multiple Myeloma Therapy Market Size, 2018-2030
7 Multiple Myeloma Therapy Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Multiple Myeloma Therapy Major Product Offerings
7.1.4 Sanofi Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Multiple Myeloma Therapy Major Product Offerings
7.2.4 Celgene Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Multiple Myeloma Therapy Major Product Offerings
7.3.4 Johnson & Johnson Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Major Product Offerings
7.4.4 GlaxoSmithKline plc Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Company Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.6 AbbVie Inc.
7.6.1 AbbVie Inc. Company Summary
7.6.2 AbbVie Inc. Business Overview
7.6.3 AbbVie Inc. Multiple Myeloma Therapy Major Product Offerings
7.6.4 AbbVie Inc. Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.6.5 AbbVie Inc. Key News & Latest Developments
7.7 Amgen Inc.
7.7.1 Amgen Inc. Company Summary
7.7.2 Amgen Inc. Business Overview
7.7.3 Amgen Inc. Multiple Myeloma Therapy Major Product Offerings
7.7.4 Amgen Inc. Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.7.5 Amgen Inc. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Multiple Myeloma Therapy Major Product Offerings
7.8.4 Novartis AG Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Millennium Pharmaceuticals
7.9.1 Millennium Pharmaceuticals Company Summary
7.9.2 Millennium Pharmaceuticals Business Overview
7.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Major Product Offerings
7.9.4 Millennium Pharmaceuticals Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.9.5 Millennium Pharmaceuticals Key News & Latest Developments
7.10 Innate Pharma SA
7.10.1 Innate Pharma SA Company Summary
7.10.2 Innate Pharma SA Business Overview
7.10.3 Innate Pharma SA Multiple Myeloma Therapy Major Product Offerings
7.10.4 Innate Pharma SA Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
7.10.5 Innate Pharma SA Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Multiple Myeloma Therapy Market Opportunities & Trends in Global Market
Table 2. Multiple Myeloma Therapy Market Drivers in Global Market
Table 3. Multiple Myeloma Therapy Market Restraints in Global Market
Table 4. Key Players of Multiple Myeloma Therapy in Global Market
Table 5. Top Multiple Myeloma Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Multiple Myeloma Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Multiple Myeloma Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Multiple Myeloma Therapy Product Type
Table 9. List of Global Tier 1 Multiple Myeloma Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multiple Myeloma Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Multiple Myeloma Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Multiple Myeloma Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Multiple Myeloma Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Multiple Myeloma Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Multiple Myeloma Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Multiple Myeloma Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Multiple Myeloma Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Multiple Myeloma Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Multiple Myeloma Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Multiple Myeloma Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Multiple Myeloma Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Multiple Myeloma Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Multiple Myeloma Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Multiple Myeloma Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Sanofi Company Summary
Table 31. Sanofi Multiple Myeloma Therapy Product Offerings
Table 32. Sanofi Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Celgene Company Summary
Table 35. Celgene Multiple Myeloma Therapy Product Offerings
Table 36. Celgene Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Celgene Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Multiple Myeloma Therapy Product Offerings
Table 40. Johnson & Johnson Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. GlaxoSmithKline plc Company Summary
Table 43. GlaxoSmithKline plc Multiple Myeloma Therapy Product Offerings
Table 44. GlaxoSmithKline plc Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline plc Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd Company Summary
Table 47. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Product Offerings
Table 48. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 50. AbbVie Inc. Company Summary
Table 51. AbbVie Inc. Multiple Myeloma Therapy Product Offerings
Table 52. AbbVie Inc. Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Inc. Key News & Latest Developments
Table 54. Amgen Inc. Company Summary
Table 55. Amgen Inc. Multiple Myeloma Therapy Product Offerings
Table 56. Amgen Inc. Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Amgen Inc. Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Multiple Myeloma Therapy Product Offerings
Table 60. Novartis AG Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Millennium Pharmaceuticals Company Summary
Table 63. Millennium Pharmaceuticals Multiple Myeloma Therapy Product Offerings
Table 64. Millennium Pharmaceuticals Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Millennium Pharmaceuticals Key News & Latest Developments
Table 66. Innate Pharma SA Company Summary
Table 67. Innate Pharma SA Multiple Myeloma Therapy Product Offerings
Table 68. Innate Pharma SA Multiple Myeloma Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Innate Pharma SA Key News & Latest Developments
List of Figures
Figure 1. Multiple Myeloma Therapy Segment by Type in 2022
Figure 2. Multiple Myeloma Therapy Segment by Application in 2022
Figure 3. Global Multiple Myeloma Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Multiple Myeloma Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Multiple Myeloma Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2022
Figure 8. By Type - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Multiple Myeloma Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Multiple Myeloma Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 16. US Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 28. China Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Multiple Myeloma Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Multiple Myeloma Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Sanofi Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline plc Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Inc. Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amgen Inc. Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis AG Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Millennium Pharmaceuticals Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Innate Pharma SA Multiple Myeloma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
